Name: Bone Marrow Transplantation Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMMD1481
Price: 4350 USD
Availability: InStock

Bone Marrow Transplantation Market Size Share Growth Opportunities and Forecast 2022

Bone Marrow Transplantation Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Bone Marrow Transplantation Market is segmented&nbsp;By Transplantation Type (Autologous Bone Marrow Transplantation, Allogenic Bone Marrow Transplantation), By Disease Indication(Leukemia,&nbsp;Lymphoma, Myeloma,&nbsp;Anemia, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Bone Marrow Transplantation Market&quot;&nbsp;is expected to grow at a high <a href="https://www.datamintelligence.com/download-sample/bone-marrow-transplantation-market">CAGR</a>&nbsp;during the forecasting period (2022-2029).
</blockquote>

<h2>Trending Topics</h2>

<a href="https://www.datamintelligence.com/download-sample/production-chemical-market">Production Chemical Market</a>

<a href="https://www.datamintelligence.com/download-sample/phosphorus-and-derivatives-market">Phosphorus &amp; Derivatives Market</a>

<a href="https://www.datamintelligence.com/download-sample/greenhouse-produce-market">Greenhouse Produce Market</a>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>
		Market Snippet by Transplantation type
		</li>
		<li>
		Market Snippet by Disease Indication
		</li>
		<li>
		Market Snippet by End User
		</li>
		<li>
		DataM CLO Scenario
		</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Increasing prevalence of cancers and anemia&nbsp;&nbsp;&nbsp;
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				High cost of the treatment
				</li>
				<li>
				&nbsp;Scarcity of bone marrow donors
				</li>
			</ol>
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis&nbsp;

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Key Companies to Watch
		</li>
		<li>
		Epidemiology
		</li>
	</ol>
	</li>
	<li>
	By Transplantation Type

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transplantation Type
			</li>
			<li>
			Market Attractiveness Index, By Transplantation Type
			</li>
		</ol>
		</li>
		<li>
		Autologous Bone Marrow Transplantation

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Allogenic Bone Marrow Transplantation
		</li>
	</ol>
	</li>
	<li>
	By Disease Indication

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
			</li>
			<li>
			Market Attractiveness Index, By Disease Indication
			</li>
		</ol>
		</li>
		<li>
		Leukemia

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		&nbsp;Lymphoma
		</li>
		<li>
		Myeloma
		</li>
		<li>
		&nbsp;Anemia
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By End User

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Attractiveness Index, By End User
			</li>
		</ol>
		</li>
		<li>
		Hospitals

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Clinics
		</li>
		<li>
		Ambulatory Surgical Centers
		</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>
		Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transplantation Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transplantation Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transplantation Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transplantation Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transplantation Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Global Market Competitive Landscape

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor Bone Marrow Transplantation Strategy Analysis
		</li>
		<li>
		Comparative Product Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	Global Market - Company Profiles

	<ol>
		<li>
		&nbsp;&nbsp;All Cells LLC

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		STEMCELL Technologies
		</li>
		<li>
		&nbsp;Merck Millipore Corp
		</li>
		<li>
		Sanofi-Aventis LLC
		</li>
		<li>
		Lonza Group Ltd&nbsp;
		</li>
		<li>
		Hemacare Corporation
		</li>
		<li>
		&nbsp;Cellular Dynamics International&nbsp;
		</li>
		<li>
		ReachBio LLC&nbsp;
		</li>
		<li>
		Conversant Bio
		</li>
		<li>
		Life Line Cell Technology
		</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables and Figures</h2>

LIST OF TABLES

TABLE 01.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, 2021, 2025 &amp; 2029, BY TRANSPLANTATION TYPE, ($MILLION)

TABLE 02.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, 2021, 2025 &amp; 2029, BY DISEASE INDICATION, ($MILLION)

TABLE 03.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE 2021, 2025 &amp; 2029, BY END USER, ($MILLION)

TABLE 04.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE 2021, 2025 &amp; 2029, BY REGION, ($MILLION)

&nbsp;TABLE 05.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE 2021, 2025 &amp; 2029 (%), BY TRANSPLANTATION TYPE ($MILLION)

TABLE 06.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 07.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE 2021, 2025 &amp; 2029 (%), BY DISEASE INDICATION ($MILLION)

TABLE 08.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 09.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE 2021, 2025 &amp; 2029 (%), BY END USER ($MILLION)

TABLE 10.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY END USER, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 11.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE 2021, 2025 &amp; 2029 (%), BY REGION ($MILLION)

TABLE 12.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY REGION, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 13.&nbsp; NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

TABLE 13.&nbsp; NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

TABLE 11.&nbsp; NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY END USER, 2018&ndash;2029 ($MILLION)

TABLE 12.&nbsp; NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 13.&nbsp; SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

TABLE 13.&nbsp; SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

TABLE 14.&nbsp; SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY END USER, 2018&ndash;2029 ($MILLION)

TABLE 15.&nbsp; SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 16.&nbsp; EUROPE BONE MARROW TRANSPLANTATION MARKET VALUE, BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

EUROPE BONE MARROW TRANSPLANTATION MARKET VALUE, BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

TABLE 17.&nbsp; EUROPE BONE MARROW TRANSPLANTATION MARKET VALUE, BY END USER, 2018&ndash;2029 ($MILLION)

TABLE 18.&nbsp; EUROPE BONE MARROW TRANSPLANTATION MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 19.&nbsp; ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET VALUE, BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

TABLE 19.&nbsp; ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET VALUE, BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

TABLE 20.&nbsp; ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET VALUE, BY END USER, 2018&ndash;2029 ($MILLION)

TABLE 21.&nbsp; ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET VALUE, BY COUNTRY, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 22.&nbsp; MIDDLE EAST &amp; AFRICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

TABLE 22.&nbsp; MIDDLE EAST &amp; AFRICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

TABLE 23.&nbsp; MIDDLE EAST &amp; AFRICA BONE MARROW TRANSPLANTATION MARKET VALUE, BY END USER, 2018&ndash;2029 ($MILLION)

&nbsp;TABLE 24.&nbsp; ALL CELLS LLC: OVERVIEW

TABLE 25.&nbsp; ALL CELLS LLC: PRODUCT PORTFOLIO

TABLE 26.&nbsp; ALL CELLS LLC: KEY DEVELOPMENTS

TABLE 27.&nbsp; STEMCELL TECHNOLOGIES: OVERVIEW

TABLE 28.&nbsp; STEMCELL TECHNOLOGIES: PRODUCT PORTFOLIO

TABLE 28.&nbsp; STEMCELL TECHNOLOGIES: KEY DEVELOPMENTS

TABLE 29.&nbsp; MERCK MILLIPORE CORP: OVERVIEW

TABLE 30.&nbsp; MERCK MILLIPORE CORP: PRODUCT PORTFOLIO

TABLE 31.&nbsp; MERCK MILLIPORE CORP: KEY DEVELOPMENTS

TABLE 32.&nbsp; SANOFI-AVENTIS LLC: OVERVIEW

TABLE 33.&nbsp; SANOFI-AVENTIS LLC: PRODUCT PORTFOLIO

TABLE 34.&nbsp; SANOFI-AVENTIS LLC: KEY DEVELOPMENTS

TABLE 35.&nbsp; LONZA GROUP LTD OVERVIEW

TABLE 36.&nbsp; LONZA GROUP LTD: PRODUCT PORTFOLIO

TABLE 37.&nbsp; LONZA GROUP LTD: KEY DEVELOPMENTS

TABLE 38.&nbsp; HEMACARE CORPORATION: OVERVIEW

TABLE 39.&nbsp; HEMACARE CORPORATION: PRODUCT PORTFOLIO

TABLE 40.&nbsp; HEMACARE CORPORATION: KEY DEVELOPMENTS

TABLE 41.&nbsp; CELLULAR DYNAMICS INTERNATIONAL: OVERVIEW

TABLE 42.&nbsp; CELLULAR DYNAMICS INTERNATIONAL: PRODUCT PORTFOLIO

TABLE 43.&nbsp; CELLULAR DYNAMICS INTERNATIONAL:&nbsp; KEY DEVELOPMENTS

TABLE 44.&nbsp; REACHBIO LLC: OVERVIEW

TABLE 45.&nbsp; REACHBIO LLC: PRODUCT PORTFOLIO

TABLE 46.&nbsp; REACHBIO LLC: KEY DEVELOPMENTS

TABLE 47.&nbsp; CONVERSANT BIO: OVERVIEW

TABLE 48.&nbsp; CONVERSANT BIO: PRODUCT PORTFOLIO

TABLE 49.&nbsp; CONVERSANT BIO: KEY DEVELOPMENTS

TABLE 50.&nbsp; LIFE LINE CELL TECHNOLOGY: OVERVIEW

TABLE 51.&nbsp; LIFE LINE CELL TECHNOLOGY: PRODUCT PORTFOLIO

TABLE 52.&nbsp; LIFE LINE CELL TECHNOLOGY: KEY DEVELOPMENTS

&nbsp;

LIST OF FIGURES

FIGURE 01.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE, 2018 &amp; 2029 (%), BY TRANSPLANTATION TYPE

FIGURE 02.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE, 2018 &amp; 2029 (%), BY DISEASE INDICATION

FIGURE 03.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE, 2018 &amp; 2029 (%), BY END USER

FIGURE 04.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET SHARE, 2018 &amp; 2029 (%), BY REGION

&nbsp;FIGURE 05.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, 2018 - 2029 AND YEAR ON YEAR GROWTH

FIGURE 06.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY TRANSPLANTATION TYPE

FIGURE 07. GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY AUTOLOGOUS BONE MARROW TRANSPLANTATION, 2018&ndash;2029 ($MILLION)

FIGURE 08.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY ALLOGENIC BONE MARROW TRANSPLANTATION, 2018&ndash;2029 ($MILLION)

FIGURE 09.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY DISEASE INDICATION

FIGURE 10.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY LEUKEMIA, 2018&ndash;2029 ($MILLION)

FIGURE 11.&nbsp;&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY LYMPHOMA, 2018&ndash;2029 ($MILLION)

FIGURE 12.&nbsp;&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY ANEMIA &nbsp;2018&ndash;2029 ($MILLION)

FIGURE 12.&nbsp;&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY OTHERS &nbsp;2018&ndash;2029 ($MILLION)

&nbsp;FIGURE 13.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY END USER

<a name="_GoBack"></a>FIGURE 14.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY HOSPITALS, 2018&ndash;2029 ($MILLION)

FIGURE 15.&nbsp;&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY CLINICS, 2018&ndash;2029 ($MILLION)

FIGURE 16.&nbsp;&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET VALUE, BY AMBULATORY SURGICAL CENTERS &nbsp;2018&ndash;2029 ($MILLION)

&nbsp;FIGURE 13.&nbsp; GLOBAL BONE MARROW TRANSPLANTATION MARKET YEAR ON YEAR GROWTH 2018 TO 2029 (%), BY REGION

FIGURE 14.&nbsp; &nbsp;NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 15.&nbsp;&nbsp; NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 16.&nbsp; &nbsp;NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

FIGURE 16.&nbsp; &nbsp;NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY END USER, 2018&ndash;2029 ($MILLION)

FIGURE 17.&nbsp; NORTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

&nbsp;FIGURE 18.&nbsp; SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 19.&nbsp;&nbsp; SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY TRANSPLANTATION TYPE, 2018-2029($MILLION)

FIGURE 20. SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

FIGURE 20. SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY END USER, 2018&ndash;2029 ($MILLION)

FIGURE 21. SOUTH AMERICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

&nbsp;FIGURE 22.&nbsp; &nbsp;EUROPE BONE MARROW TRANSPLANTATION MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 23.&nbsp; &nbsp;EUROPE BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 24.&nbsp; EUROPE BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

FIGURE 24.&nbsp; EUROPE BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY END USER, 2018&ndash;2029 ($MILLION)

FIGURE 25.&nbsp; EUROPE BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

&nbsp;FIGURE 26.&nbsp; &nbsp;ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 27.&nbsp; ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 28.&nbsp; &nbsp;ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

FIGURE 28.&nbsp; &nbsp;ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY END USER, 2018&ndash;2029 ($MILLION)

FIGURE 29.&nbsp; ASIA PACIFIC BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY COUNTRIES, 2018&ndash;2029 ($MILLION)

&nbsp;FIGURE 30.&nbsp; MIDDLE EAST AND AFRICA BONE MARROW TRANSPLANTATION MARKET VALUE, 2018&ndash;2029 ($MILLION)

FIGURE 31.&nbsp; MIDDLE EAST AND AFRICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY TRANSPLANTATION TYPE, 2018&ndash;2029 ($MILLION)

FIGURE 31.&nbsp; MIDDLE EAST AND AFRICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY DISEASE INDICATION, 2018&ndash;2029 ($MILLION)

FIGURE 32.&nbsp; MIDDLE EAST &amp; AFRICA BONE MARROW TRANSPLANTATION MARKET SHARE (%), BY END USER, 2018&ndash;2029 ($MILLION)

FIGURE 33.&nbsp; ALL CELLS LLC: FINANCIALS

FIGURE 34.&nbsp; STEMCELL TECHNOLOGIES: FINANCIALS

FIGURE 35.&nbsp; MERCK MILLIPORE CORP: FINANCIALS

FIGURE 36.&nbsp; &nbsp;CONVERSANT BIO: FINANCIALS

FIGURE 37.&nbsp; LONZA GROUP LTD: FINANCIALS

FIGURE 38.&nbsp; HEMACARE CORPORATION: FINANCIALS

FIGURE 39.&nbsp; &nbsp;CELLULAR DYNAMICS INTERNATIONAL: FINANCIALS

FIGURE 40.&nbsp; REACHBIO LLC: FINANCIALS

FIGURE 41.&nbsp; SANOFI-AVENTIS LLC: FINANCIALS

FIGURE 42.&nbsp; LIFE LINE CELL TECHNOLOGY: FINANCIALS